Paper · 23934178
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity.
Pattanayak V and 5 others. Nat Biotechnol, 2013. Cited by 1,133 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Papers, record 23934178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23934178
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endonucleases | Major topic |
| Genetic Engineering | Major topic |
| High-Throughput Nucleotide Sequencing | Major topic |
| Sequence Analysis, DNA | Major topic |
| Bacterial Proteins | |
| DNA | |
| Genome | |
| Genomics | |
| HEK293 Cells | |
| Humans | |
| Streptococcus pyogenes | |
| RNA, Small Untranslated |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Howard Hughes Medical Institute | United States | PubMed | PubMed | ||
| T32 GM007753 | NIGMS NIH HHS | United States | T32GM007753 | PubMed and NIH | NIH RePORTER |
| R01GM073794-05 | NIGMS NIH HHS | United States | R01GM073794 | PubMed and NIH | NIH RePORTER |
| R01 GM073794 | NIGMS NIH HHS | United States | R01GM073794 | PubMed and NIH | NIH RePORTER |
| T32GM007753 | NIGMS NIH HHS | United States | T32GM007753 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 24,022,156 | Staying on target with CRISPR-Cas. | https://conductscience.org/library/papers/24022156 |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,360,964 | Efficient genome editing in zebrafish using a CRISPR-Cas system. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23360964 | PubMed |
| 2 | 23,360,965 | RNA-guided editing of bacterial genomes using CRISPR-Cas systems. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23360965 | PubMed |
| 3 | 19,540,188 | Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. | Cell Stem Cell | 2009 | https://conductscience.org/library/papers/19540188 | PubMed |
| 4 | 21,151,125 | Targeted integration in rat and mouse embryos with zinc-finger nucleases. | Nat Biotechnol | 2011 | https://conductscience.org/library/papers/21151125 | PubMed |
| 5 | 23,452,860 | Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. | Cell | 2013 | https://conductscience.org/library/papers/23452860 | PubMed |
| 6 | 21,813,460 | The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21813460 | PubMed |
| 7 | 22,745,249 | A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. | Science | 2012 | https://conductscience.org/library/papers/22745249 | PubMed |
| 8 | 21,822,241 | Targeted gene disruption in somatic zebrafish cells using engineered TALENs. | Nat Biotechnol | 2011 | https://conductscience.org/library/papers/21822241 | PubMed |
| 9 | 18,500,337 | Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. | Nat Biotechnol | 2008 | https://conductscience.org/library/papers/18500337 | PubMed |
| 10 | 23,287,718 | Multiplex genome engineering using CRISPR/Cas systems. | Science | 2013 | https://conductscience.org/library/papers/23287718 | PubMed |
1 to 10 of 21
See all 21 referencesCited by820
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,133 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,910,235 | Human Induced Pluripotent Stem Cells in Rare Neurological Disorders: Opportunities and Challenges for Disease Modeling and Drug Discovery. | Stem Cells Int | 2026 | https://conductscience.org/library/papers/42910235 | PubMed |
| 42,877,411 | Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical application. | Front Genome Ed | 2026 | https://conductscience.org/library/papers/42877411 | PubMed |
| 42,742,174 | Highly efficient base editing at PCSK9 and normal human embryo development. | Nature | 2026 | https://conductscience.org/library/papers/42742174 | PubMed |
| 42,694,036 | Three hydrophobic surface binding a proteins link surface hydrophobicity to sporulation, biofilm formation, and host interaction in Mucor lusitanicus. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42694036 | PubMed |
| 42,649,204 | Single-cell and in vivo profiling reveal heterogeneous and organ-specific CRISPR-Cas9 off-target and translocation outcomes. | Nat Commun | 2026 | https://conductscience.org/library/papers/42649204 | PubMed |
| 42,620,363 | Genomic repeats for single-cell molecular recording. | bioRxiv | 2026 | https://conductscience.org/library/papers/42620363 | PubMed |
| 42,333,535 | SNIPSNP: precision design of CRISPR/Cas9 knock-in reagents for variant correction and disease modeling. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42333535 | PubMed |
| 42,310,027 | iSCORE-PD: an isogenic stem cell collection to research Parkinson's disease. | Nat Commun | 2026 | https://conductscience.org/library/papers/42310027 | PubMed |
| 42,273,291 | Design and validation of an inducible and curable EvolvR system for directed evolution in Corynebacterium glutamicum. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42273291 | PubMed |
| 42,170,219 | Off-target detection of CRISPR-Cas9 nuclease in vitro with CROFT-Seq. | Synth Biol (Oxf) | 2026 | https://conductscience.org/library/papers/42170219 | PubMed |
1 to 10 of 820
See all 820 cited byGenes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDK8 | 1,024 | PubTator's text mining | https://conductscience.org/library/genes/1024 | NCBI Gene |
| CLTA | 1,211 | PubTator's text mining | https://conductscience.org/library/genes/1211 | NCBI Gene |
| NEB | 4,703 | PubTator's text mining | https://conductscience.org/library/genes/4703 | NCBI Gene |
| NR1H4 | 9,971 | PubTator's text mining | https://conductscience.org/library/genes/9971 | NCBI Gene |
| SEPHS2 | 22,928 | PubTator's text mining | https://conductscience.org/library/genes/22928 | NCBI Gene |
| SLC9A2 | 6,549 | PubTator's text mining | https://conductscience.org/library/genes/6549 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23934178
GET https://conductscience.org/api/papers/v1/23934178/references?page=2